Tag: Comparison
China’s Biotech Boom: 5,215 Clinical Drug Trials in 2025
China registered a record 5,215 clinical drug trials in 2025, up 23% from 2024. This market intelligence briefing covers opportunities, risks, and entry points for foreign pharma and biotech investors.
China’s Auditor Crackdown Intensifies: Draft Amendment Targets Audit Misconduct
China’s draft audit law amendment introduces harsher penalties for audit firms and individual accountants. Here’s what foreign businesses need to know about the PwC-Evergrande aftermath and rising compliance costs.
Polestar’s U.S. Exit Marks First Major Casualty of Chinese Auto Tech Ban
Geely-backed Polestar is forced out of the U.S. market under new Chinese auto tech restrictions. What this signals for the EV industry and global supply chains.
Shenzhen’s Qianhai Zone Expands Tax Benefits for Foreign-Invested Firms
Qianhai’s expanded IIT and CIT preferential policies cut costs for foreign talent and businesses in Shenzhen. See what changed and how to qualify for the 15% rate.
China’s 2026 Legislative Agenda: 5 Laws Foreign Businesses Must Track Before Year-End
China's NPC is advancing five major laws this week that will reshape procurement, trademarks, financial regulation, insolvency, and tax enforcement. Here's what foreign businesses must do before the final votes.
Hong Kong and Shanghai Race to Expand Offshore Yuan Services
Hong Kong readies new offshore yuan initiatives as Shanghai unveils its offshore finance action plan. What foreign businesses need to know about China's dual-hub RMB strategy.